Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    10022591 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Enrolling by invitation Evaluation of Omegaven™ Parenteral Nutrition in Patients With TPN-Induced Cholestasis
Conditions: Parenteral Nutrition Associated Liver Disease PNALD;   Cholestasis
Intervention: Drug: Omegaven™
2 Available Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease
Conditions: Cholestasis;   Short Bowel Syndrome
Intervention: Drug: Omegaven
3 Terminated Reduction of Neonatal Parenteral Nutrition Associated Cholestasis Through Lipid Emulsions
Condition: Intrahepatic, Cholestasis
Interventions: Other: SMOFlipid;   Other: Lipofundin
4 Recruiting Omegaven Treatment of Parenteral Nutrition (PN) Induced Liver Injury
Condition: Liver Injury
Interventions: Drug: Omegaven™;   Other: Historical Controls

Study has passed its completion date and status has not been verified in more than two years.